The increasing availability of large-scale human exome and genome sequencing data combined with links to phenotype should, in time, provide information about the in vivo consequences of ADH1B deficiency. The gene discussed is ADH1B; the disease is hyperinsulinemic hypoglycemia, familial, 4.